ADZE BIOTECHNOLOGY
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founded in 2019 and is based in Coral Gables, Florida.
ADZE BIOTECHNOLOGY
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Coral Gables, Florida, United States
Country:
United States
Website Url:
http://www.adzebiotech.com
Total Employee:
1+
Status:
Active
Contact:
+9177439401
Total Funding:
6.15 M USD
Similar Organizations
cCAM Biotherapeutics
cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
InnoRx
InnoRx is a development stage company, develops novel therapies for the ophthalmology market.
Red C Biotech
Red C Biotech is a pre-clinical, development stage company that aims to save lives by collaborating with organizations.
Saronic Biotechnology
Saronic Biotechnology, Inc. is committed to developing novel immunotherapies to cure liver cancer.
ViaMune
ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers.
VISKA Bio
VISKA Bio is an early-stage immunotherapy platform that engages localized immunogenic cell death to treat and prevent cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.adzebiotech.com
- Host name: 6.9.214.35.bc.googleusercontent.com
- IP address: 35.214.9.6
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Adze Biotechnology"
About Adze Biotechnology | Cancer Immunotherapy
Mr Hopps spent many years working with biotechnology companies in the public markets while at UBS and First Albany Corp. Prior to co-founding Adze Biotechnology, Mr Hopps was a partner …See details»
Adze Biotechnology | Oncolytic Immunotherapies for Cancer
Apr 8, 2024 Adze Biotechnology is developing a growing platform of immunotherapies that utilize our proprietary and targeted oncolytic viral backbone. Our oncolytic backbone enables …See details»
Adze Biotechnology - Crunchbase Company Profile
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo …See details»
Adze Biotechnology Inc - Dun & Bradstreet
See other industries within the Manufacturing sector: Aerospace Product and Parts Manufacturing , Agriculture, Construction, and Mining Machinery Manufacturing , Alumina and Aluminum …See details»
Adze Biotechnology, Inc. - Drug pipelines, Patents, Clinical trials ...
KING OF PRUSSIA, Pa., Feb. 22, 2023 /PRNewswire/ -- Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to …See details»
Adze Biotechnology - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Adze Biotechnology. Use the PitchBook Platform to explore the full profile.See details»
ADZE Biotechnology - Products, Competitors, Financials, …
Apr 8, 2024 — Sidney Hopps, Chief Executive Officer of Adze CORAL GABLES, FLORIDA, US, April 8, 2024 / EINPresswire.com / -- Dr. Paola Grandi, PhD, MBA is the Head of Pre-Clinical …See details»
Adze Biotechnology Completes $6.2 Million First …
Mar 16, 2023 The Adze-1.17 platform, with an attractive safety profile, has the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit Adzebiotech.com. Investor & Media …See details»
Adze Biotechnology - Overview, News & Similar companies
Adze Biotechnology contact info: Phone number: (917) 743-9401 Website: www.adzebiotech.com What does Adze Biotechnology do? Adze Biotechnology is developing oncolytic …See details»
Adze Biotechnology Granted Patent for its Proprietary Oncolytic
Feb 2, 2023 For more information, please visit Adzebiotech.com. Investor & Media Contact: Sidney Hopps, CEO 917.743.9401 [email protected]. Adze Biotechnology, Inc. 2332 …See details»
ADZE Biotechnology | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Adze Biotechnology Granted Patent for its Proprietary Oncolytic ...
Feb 1, 2023 For more information, please visit Adzebiotech.com Investor & Media Contact: Sidney Hopps, CEO 917.743.9401 [email protected] Adze Biotechnology, Inc. 2332 …See details»
Adze Biotechnology - Contacts, Employees, Board Members
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.See details»
Adze Biotechnology Completes $6.2 Million First Closing of Series …
Mar 16, 2023 The Adze-1.17 platform, with an attractive safety profile, has the versatility to be developed alone or combined with a variety of other treatment options. For more information, …See details»
Developing oncolytic immunotherapies | Adze Biotechnology …
At Adze Biotechnology, our scientists are developing oncolytic immunotherapies with the goal of treating solid tumors directly while making patients immune against their own cancer.See details»
Adze Biotechnology - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Adze Biotechnology Announces Orphan Drug Designation …
Feb 7, 2023 The Adze-1.17 platform, with an attractive safety profile, has the versatility to be developed alone or combined with a variety of other treatment options. For more information, …See details»
Partnering with Adze Biotechnology
We invite you to connect with us at [email protected] to discuss potential opportunities. Partnering opportunities include: An expanding pipeline of oncolytic immunotherapies focused …See details»
Adze Biotechnology Pipeline
Our platform of intravenously & intratumorally deliverable oncolytic immunotherapies enables us to pursue multiple indications across broad patient populationsSee details»
News - Adze Biotechnology
Feb 1, 2023 This Notice of Allowance for broad recombinant adenovirus claims is another important step forward for ADZE, which further strengthens and expands our intellectual …See details»